| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 990183 | Value in Health Regional Issues | 2012 | 6 Pages |
Abstract
At IMSS, sunitinib+BSC would provide substantial clinical benefits to patients suffering unresectable pancreatic NET, although the latter would increase medical costs of treatment and clinical follow up.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Emilio MSc, Alfredo MD, Gustavo BEcon, Consuelo I. MD, JoaquÃn BEng, Rosa MarÃa MSc,